Delivering on the promise of early detection with liquid biopsies

Liquid biopsy approaches are relatively well developed for cancer therapy monitoring and disease relapse, but they also have incredible potential in the cancer early detection and screening field. There are, however, several challenges to overcome before this potential can be met. Research in this a...

Descripción completa

Detalles Bibliográficos
Autor principal: Crosby, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811021/
https://www.ncbi.nlm.nih.gov/pubmed/35013576
http://dx.doi.org/10.1038/s41416-021-01646-w
_version_ 1784644345984450560
author Crosby, David
author_facet Crosby, David
author_sort Crosby, David
collection PubMed
description Liquid biopsy approaches are relatively well developed for cancer therapy monitoring and disease relapse, but they also have incredible potential in the cancer early detection and screening field. There are, however, several challenges to overcome before this potential can be met. Research in this area needs to be cohesive and, as a driver of research, Cancer Research UK is in an ideal position to enable this.
format Online
Article
Text
id pubmed-8811021
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-88110212022-02-10 Delivering on the promise of early detection with liquid biopsies Crosby, David Br J Cancer Comment Liquid biopsy approaches are relatively well developed for cancer therapy monitoring and disease relapse, but they also have incredible potential in the cancer early detection and screening field. There are, however, several challenges to overcome before this potential can be met. Research in this area needs to be cohesive and, as a driver of research, Cancer Research UK is in an ideal position to enable this. Nature Publishing Group UK 2022-01-10 2022-02-01 /pmc/articles/PMC8811021/ /pubmed/35013576 http://dx.doi.org/10.1038/s41416-021-01646-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Comment
Crosby, David
Delivering on the promise of early detection with liquid biopsies
title Delivering on the promise of early detection with liquid biopsies
title_full Delivering on the promise of early detection with liquid biopsies
title_fullStr Delivering on the promise of early detection with liquid biopsies
title_full_unstemmed Delivering on the promise of early detection with liquid biopsies
title_short Delivering on the promise of early detection with liquid biopsies
title_sort delivering on the promise of early detection with liquid biopsies
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811021/
https://www.ncbi.nlm.nih.gov/pubmed/35013576
http://dx.doi.org/10.1038/s41416-021-01646-w
work_keys_str_mv AT crosbydavid deliveringonthepromiseofearlydetectionwithliquidbiopsies

Ejemplares similares